Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· AI x biologyAudio language not provided

AlphaFold-Metainference: predicting structural ensembles of disordered proteins

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

This video summarizes the study “AlphaFold prediction of structural ensembles of disordered proteins” by Brotzakis, Zhang, Murtada & Vendruscolo (Nature Communications, 2025) (PMID: 39952928). The authors introduce AlphaFold-Metainference, a hybrid method that uses inter-residue distance predictions from AlphaFold as structural restraints in molecular dynamics simulations to generate structural ensembles of intrinsically disordered and partially disordered proteins. By combining deep learning predictions and physical sampling, the approach yields conformational ensembles that better match experimental small-angle X-ray scattering (SAXS) and NMR data than single static models. This method extends the utility of AlphaFold beyond folded proteins, offering a route to characterize the structural heterogeneity and dynamics of disordered systems.

AI x biology · 6 min · Source published: 2025-10-15

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…